Shenzhen Wanghai Bioengineering Co., Ltd., which is controlled by Wanghai Group, is a high-tech enterprise (stock referred to as "Wanghai Bio") listed on Shenzhen Stock Exchange, focusing on the research and development of bioengineering drugs, with excellent performance, and has been selected as one of the top 50 most potential listed companies in China for two consecutive years. From June, 5438 to February, 2000, with the approval of China Securities Regulatory Commission, Neptune Bio successfully issued A shares, and all the funds raised in this issuance were used for Neptune Bio's core industries and related projects, which will greatly enhance Neptune Bio's comprehensive strength and make its development enter a new stage.
In 2002, Neptune Group won the title of the first outstanding private enterprise in Shenzhen in the selection of outstanding private enterprises in Shenzhen. Neptune Group is also the first batch of high-tech enterprises, tax payment demonstration enterprises and top 100 scientific and technological enterprises in Shenzhen. In addition to the existing two national technology centers and five modern multi-functional large-scale pharmaceutical industrial bases, Neptune Group's extensive and rich marketing resources have laid a solid foundation for Neptune products to realize market value.
Nepstar Pharmaceutical Co., Ltd. is a subsidiary of Nepstar Group, a large-scale retail chain enterprise integrating western medicine and health care products marketing, and an important market window for Nepstar products. Nepstar has more than 400 stores. It is planned that by 2005, the number of stores will reach 1000, which will spread all over major cities in China, forming an important market resource for Nepstar products. 1996 65438+ 10, Neptune star joined the American Chain Pharmacy Association (NACDS) and became the first China member of the association; In June, 2000, we joined hands with Beijing Tongrentang Group to open the first Shenzhen Beijing Tongrentang Chen Xing Pharmacy. In June 2002, it signed a contract with Medicine Shoppe and Pacific Gateway Capital LLC, the world's number one franchise pharmaceutical chain, and obtained the franchise right of Medicine Shoppe in China, marking the first international pharmaceutical chain brand entering China. This series of important measures of Neptune has built a three-dimensional, multi-level and high-level sales network for Neptune, and expanded a broad space for its development and enrichment of market resources.
Every step of Neptune's achievements can not be separated from the cordial care of the party and the government, and can not be separated from the sincere help of all walks of life. It is our bounden duty to contribute to the people and give back to the society. In the past ten years, Neptune Star Group has successively provided more than 54 million yuan for social welfare undertakings such as Project Hope, Poverty Alleviation, Flood Control in East China, Guangdong Children's Fund, China Children's Welfare, Intellectual Project of China Medical Foundation, National Endemic Disease Prevention and Control Work, Australia Star Launch, PLA Speed Skating Team and PLA Shooting Team, which has been highly praised by governments at all levels and all walks of life. Especially in the fight against SARS, Nepstar kept in mind the sacred mission of "health guardian" and donated 20 million yuan worth of health care products, medicines and cash to the medical staff fighting against SARS with a high sense of social responsibility and excellent professional spirit, which was once again commended by the government and praised by the general public.